Author:
Tseng Feng-Jen,Liu Yen-Ku,Chung Yo-Shong,Lin Yu-Ling,Chen Chia-Hung,Wang Wan-Yi,Chen Yu-Cheng,Tsai Nu-Man,Cheng Tian-Lu,Pan Ru-Yu,Hu Tsung-Ming,Lee Ru-Ping,Liao Kuang-Wen
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology
Reference30 articles.
1. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res 55:5296–5301
2. Bae DG, Gho YS, Yoon WH, Chae CB (2000) Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J Biol Chem 275:13588–13596
3. Binetruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouet J, Derbin C, Perret G, Mazie JC (2000) Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 19:1525–1533
4. Caron PC, Laird W, Co MS, Avdalovic NM, Queen C, Scheinberg DA (1992) Engineered humanized dimeric forms of IgG are more effective antibodies. J Exp Med 176:1191–1195
5. Eisenbeis CF, Grainger A, Fischer B, Baiocchi RA, Carrodeguas L, Roychowdhury S, Chen L, Banks AL, Davis T, Young D, Kelbick N, Stephens J, Byrd JC, Grever MR, Caligiuri MA, Porcu P (2004) Combination immunotherapy of B-cell non-Hodgkin’s lymphoma with rituximab and interleukin-2: a preclinical and phase I study. Clin Cancer Res 10:6101–6110
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献